Evidence map›Paper›PMID 35230742›Full record

ReviewLiver international : official journal of the International Association for the Study of the Liver2022

Hyperpolarized carbon 13 MRI in liver diseases: Recent advances and future opportunities.

Zheng Ye, Bin Song, Philip M Lee, Michael A Ohliger, Christoffer Laustsen

Open access · hybridAbstract readReview
In one paragraph

Review in Liver international : official journal of the International Association for the Study of the Liver, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Complementary hyperpolarizedNpj imaging · 2026
    Article
  4. Article
  5. Article
  6. Quo Vadis HyperpolarizedZeitschrift fur medizinische Physik · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. [6,6'-NMR in biomedicine · 2023
    Article
  11. Review
  12. Multinuclear MRI in Drug Discovery.Molecules (Basel, Switzerland) · 2022
    Review
  13. Hyperpolarized carbon 13 MRI in liver diseases: Recent advances and future opportunities.Liver international : official journal of the International Association for the Study of the Liver · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Zheng YeDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.ORCID 0000-0001-6715-0183
Bin SongDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.ORCID 0000-0001-7007-6367
Philip M LeeDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA.ORCID 0000-0002-5783-1599
Michael A OhligerDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA.
Christoffer LaustsenThe MR Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Aarhus University · DKUniversity of California, San Francisco · USSichuan University · CN

Funding

Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASHR01DK115987 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OHLIGER, MICHAEL, VON MORZE, CORNELIUS · 2018 to 2022
$2.1M
NIDDK NIH HHS R01 DK115987
6 · The paper itself

Abstract

Hyperpolarized carbon-13 magnetic resonance imaging (HP

Indexed as

Liver DiseasesMagnetic Resonance ImagingCarbon IsotopesHumansCarbon-13Carbon Isotopescarbon 13diffuse liver diseaseshyperpolarizationliver malignancymagnetic resonance imaging

Identifiers

PMID35230742
PMCPMC9313895
OpenAlexW4214522240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.